# Nuclide record nct07702292 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct07702292/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct07702292", "NCT07702292" ;
  schema:name "[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications"@en ;
  schema:description "A phase 2 trial of [68Ga]BED003 in colorectal cancer, ovarian cancer, gastric & gastro-oesophageal junction cancer and pancreatic ductal adenocarcinoma, run by Blue Earth Diagnostics, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct07702292/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07702292> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "2" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:companies <https://nuclide.cc/companies/blue-earth-diagnostics/> .
